✦ LIBER ✦

Adefovir dipivoxil (ADV) results in a consistent and significant improvement in liver histology and clinical status regardless of baseline knodell fibrosis score in patients with HBeAg+Chronic hepatitis B

✍ Scribed by Marcellin, P.; Chang, T.T.; Lim, S.G.; Tong, M.; Sievert, W.; Shiffman, M.; Jeffers, L.; Goodman, Z.; Wulfsohn, M.; Fallis, R.; Fry, J.; Brosgart, C.

Book ID: 123129105
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 240 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83607-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1156 48 weeks of adefovir dipivoxil (ADV

1156 48 weeks of adefovir dipivoxil (ADV) results in a consistent and significant improvement in liver histology and virological status regardless of baseline knodell fibrosis score in patients with HBEAG- chronic hepatitis B

✍ MARCELLIN, P; HADZIYANNIS, S; TASSOPOULOS, N; HEATHCOTE, E; CHANG, T; KITIS, G; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

7 Adefovir dipivoxil (ADV) provides sign

7 Adefovir dipivoxil (ADV) provides significant clinical benefit, reduces meld score and prevents transplantation in chronic hepatitis B patients wait-listed for liver transplantation (OLT) with lamivudine-resistance (LAM-R)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB